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peptides in the fetal sheep lung
Augusto F. Schmidt1, Paranthaman S. Kannan1, Matthew W. Kemp2, Boris W. Kramer3, 
John P. Newnham2, Alan H. Jobe1, and Suhas G. Kallapur1
1Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA 
2School of Women's and Infants' Health, The University of Western Australia, Perth, WA, 
Australia 3Department of Pediatrics, Maastricht University Medical Center, Maastricht, 
Netherlands
Abstract
Background—Damage-associated molecular patterns (DAMPs) and antimicrobial peptides 
(AMPs) are components of pulmonary innate immunity and tissue repair. We hypothesized that 
DAMPs and AMPs would increase in response to fetal pulmonary inflammation caused by 
chorioamnionitis in a time-dependent manner.
Methods—Fetal sheep were exposed to intra-amniotic saline or LPS (10mg) between 5 hours 
and 15 days prior to preterm delivery at 125±2 days. Lung tissue mRNAs for pro-inflammatory 
cytokines; AMPs: myeloid antimicrobial peptide-29 (MAP29), dodecapeptide, sheep beta-
defensin-1 (SBD1), sheep beta-defensin-2 (SBD2); DAMPs: IL-1α, lactoferrin, heat-shock 
protein-70 (HSP70), high-mobility group box protein-B1 (HMGB1), receptor for advanced 
glycation endproducts (RAGE) were measured by RT-qPCR. Immunohistochemistry of DAMPs 
and in situ hybridization of AMPs was performed.
Results—IL-1α, IL-1β, IL-6, IL-8, IL-10, MCP-1, and TNF-α mRNA increased after LPS 
exposure. MAP29, dodecapeptide, SBD1 and SBD2 mRNA were suppressed at 24 hours. MAP29 
and dodecapeptide mRNA then increased at 8 days. Lactoferrin increased at 24 hours. There were 
no changes for HMGB1, HSP70 or RAGE. MAP29 and dodecapeptide localized to alveolar cells, 
increased 8 days after exposure to LPS.
Conclusion—AMPs are initially suppressed in the fetal lung by LPS-induced chorioamnionitis. 
The late induction of MAP29 and Dodecapeptide may be related to lung repair.
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Introduction
Chorioamnionitis is a frequent cause of fetal inflammation and the lung is an important 
organ in initiating the fetal inflammatory response (1). Chorioamnionitis also has been 
inconsistently associated with bronchopulmonary dysplasia (BPD), with some studies 
reporting no association (2), while others report a positive association (3). A recent meta-
analysis showed association of increased BPD with histological chorioamnionitis (4). 
However, in animal models of chorioamnionitis, the lung injury observed is mild and 
resolves despite continued exposure to proinflammatory mediators (5, 6), suggesting 
participation of repair mechanisms following the initial inflammatory insult.
In fetal lambs, intra-amniotic bacterial LPS induces chorioamnionitis and lung inflammation 
(7). LPS signals the innate immune response by binding to the Toll-like receptor 4 (TLR4) 
and intraamniotic LPS increases TLR4 mRNA expression and protein in the fetal lung (8, 
9). The TLRs are part of a group of receptors called pattern recognition receptors (PRRs), 
which recognize microorganisms through pathogen-associated molecular patterns (PAMPs), 
as well as non-infectious material and endogenous molecules released during cell injury 
called damage-associated molecular patterns (DAMPs) (8, 10).
DAMPs are constitutively present in the cytoplasm, nucleus and granules of cells such as 
leukocytes and epithelial cells. They can activate both innate and adaptive immunity, being 
quickly released by degranulation or cell necrosis in response to infection or tissue injury, 
and can also be induced in response to cytokines (10). Several DAMPs have been identified, 
including high-mobility group box-1 (HMGB1), heat shock proteins (HSP) and lactoferrin. 
These DAMPs are able to recruit and activate inflammatory cells, including dendritic cells 
and are able to interact with both TLRs and IL-1 receptor. Even though not formally 
considered DAMPs, IL-1α and Lactoferrin have similar characteristics being constitutively 
expressed and trigger inflammatory responses upon release from necrotic cells (10).
Antimicrobial peptides (AMPs) are an essential part of the innate immune response. They 
not only have direct antimicrobial activity but are also involved in the modulation of 
inflammation and healing (11). Defensins and cathelicidins, the most extensively studied 
AMPs in mammals, are large cationic peptides with antimicrobial and immunomodulatory 
activity (12). In sheep, two β-defensins have been described: β-defensin-1 (SBD1), and β-
defensin 2 (SBD2) (13, 14). Several cathelicidins also have been described in sheep and the 
myeloid antimicrobial peptide 29 (MAP29) has been the most studied. The expression of 
defensins and cathelicidins are developmentally regulated with increased expression towards 
the end of gestation and with a subsequent postnatal decrease in different fetal tissues 
(13-15). However their role in the fetal inflammatory response and tissue repair remains to 
be further elucidated. Therefore, we hypothesized that AMPs and DAMPs would increase 
with pulmonary inflammation from chorioamnionitis. We report novel information 
regarding the time course of expression of inflammatory cytokines and expression of 
DAMPs and AMPs in a clinically relevant preterm animal model.
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Results
Animals
All animals exposed to intraamniotic LPS or saline were alive at delivery (table 1). The pH 
values were low because the ewes were killed prior to delivery of the fetuses, which resulted 
in high fetal pCO2 values. We previously reported decreased lymphocytes in the cord blood 
at 5, 12, and 24 hours and increased neutrophils at 8 days for this series of animals (16).
AMPs
The mRNA levels of the β-defensins (SBD1 and SBD2) and cathelicidins (MAP29 and 
dodecapeptide) decreased 24 hours after LPS exposure (Figure 1). However, the mRNA 
levels of the cathelicidins, had an 8-fold increased expression at 8 days. In contrast, the 
mRNA levels of SBD1 and SBD2 returned to levels similar to control by 8 days.
Localization of cathelicidins mRNA
In order to identify the location of the increased expression of cathelicidins at 8 days we 
performed in situ hybridization for cathelin-related peptide, which cross-reacts with all the 
sheep cathelicidins. Lung sections from control lambs expressed cathelicidin mRNAs 
localized to the peripheral lung. The cell type appeared to be consistent with alveolar type II 
cells and occasional inflammatory cells. The number of positive cells and intensity of 
staining increased at 8 days after IA LPS exposure (Figure 2).
Expression of DAMPs
Expression of IL-1α increased at 12 hours after LPS (Figure 3). The mRNA for lactoferrin 
increased 24 hours after exposure. There were no differences in the mRNA levels for 
HMGB1, RAGE, or HSP70.
Immunolocalization of DAMPs
To characterize the expression of DAMPs in the lung we performed immunohistochemistry 
for lactoferrin, HMGB1, RAGE, and HSP70 (Figure 4). The bronchial glands and epithelial 
cells of the bronchi immunostained for lactoferrin (Figure 4A-B). The immunostaining for 
HMGB1 was diffuse and intense in bronchial epithelial cells, submucosal gland epithelium, 
alveolar epithelium and inflammatory cells (Figure 4C-D). The immunostaining for RAGE, 
the HMGB1 receptor, was also in similar location as HMGB1, although the staining 
appeared to be less intense (Figure 4E-F). Immunostaining for HSP70 was in occasional 
airway epithelial cells, and even less frequently in inflammatory and vascular smooth 
muscle cells. There was an apparent increase in the immunostaining for HSP70 in the airway 
epithelial cells at 24 hours after LPS exposure (Figure 4 G-H).
Pro-inflammatory cytokines
Expression of the pro-inflammatory cytokines IL-1β, TNF-α, MCP-1, and IL-8 were 
increased after LPS exposure (Figure 5). Three temporal patterns of expression were 
detected. We found IL-6 had the earliest peak, at 5 hours followed by a subsequent decrease. 
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IL-1β, MCP-1 and IL-10 were significantly increased 5h-12h after exposure, peaking at 2 
days. TNF-α and IL-10 were increased only at 2 days.
Discussion
We report the dynamic expression of AMPs and DAMPs with distinct temporal patterns of 
expression in the fetal lung following intra-amniotic exposure to LPS. To our knowledge 
this is the first study to report the expression AMPs and DAMPs in the preterm fetal lung in 
response to intrauterine inflammation. The expression of several AMPs decreased 1d after 
exposure to IA LPS. The finding that cathelicidins are subsequently induced in the lung 
following LPS exposure only after 8 days is particularly interesting given their role in lung 
repair. We previously reported that chorioamnionitis induced early lung injury followed by 
proliferation, consistent with early suppression followed by increased cathelicidin 
expression detected in this study (17). These results add to our understanding of how 
antenatal inflammation may be inconsistently associated with bronchopulmonary dysplasia 
depending on the time of exposure (4, 6).
Several β-defensins have been described in humans, but only two in sheep, which are 
characteristically expressed in epithelial cells. In humans, β-defensin 1 is constitutively 
expressed and not induced (18), while β-defensin 2 is induced in pulmonary epithelial cells 
in response to LPS following activation of nuclear factor kappa B (NF-κB) (19). In sheep, 
expression of SBD1 progressively increases in the bronchiolar-alveolar junction from 30 
days prior to term to 15 days postnatal (13). In normal fetuses and neonatal sheep, β-
defensin 2 is expressed constitutively in small amounts in the lungs (14). SBD1 was up 
regulated in response to viral infection (20), but suppressed in infection by gram-negative 
bacterial (21). Previous studies have shown a large individual variability in the 
developmental expression of β-defensins, which we also observed in our samples (13, 14). 
We demonstrate that the intraamniotic administration of the gram-negative bacterial cell 
wall product LPS also suppressed SBD1 and SBD2 early after exposure.
The only known human cathelicidin is LL-37, which is produced by neutrophils, 
macrophages and epithelial cells (22). The pulmonary expression of LL-37 can be induced 
by pulmonary or systemic infection, and LL-37 expression correlates with TNF-α levels 
(13). Of the several cathelicidins described in sheep, the myeloid antimicrobial peptide 29 
(MAP29) was highly effective against common gram-positive and gram-negative bacteria 
(23).
Interestingly, in our study, cathelicidins and defensins were initially suppressed after LPS 
exposure. Given their antimicrobial role, this suppression could potentially increase fetal 
susceptibility to further infection from microorganisms. Suppression of the cathelicidin 
MAP29 was observed in pulmonary infection of neonatal lamb with gram-negative bacteria, 
in contrast to the previously reported induction following viral infection suggesting 
differential roles in bacterial or viral infections (20, 21).
Both cathelicidins and defensins demonstrate important immunomodulatory function. They 
can directly recruit leukocytes as well as induce the expression of chemokines. Cathelicidins 
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also inhibit TLR4 mediated release of cytokines in dendritic cells and macrophages as well 
as release of TNF- from human monocytes (24, 25). The complex functions of AMPs 
suggest an important role in the regulation of the immune response. The early suppression 
we observed is potentially significant for the fine-tuning of the fetal inflammatory response 
to chorioamnionitis in the preterm lung.
Besides their role in modulating inflammation AMPs are also important for tissue healing 
following injury or inflammation. The human β-defensin 2 stimulates migration and 
proliferation of endothelial cells to wounds, helping wound closure (26). Specifically in 
pulmonary cells, neutrophil-derived human defensins enhance proliferation of epithelial 
cells, accelerating wound closure. This effect is mediated by activation of the EGF receptor 
(EGFR) and its downstream pathway (27). Defensins are also important for cell 
differentiation during wound healing in the lung. After injury, defensins induce expression 
of mucins MUC5B and MUC5A in cells of the epithelium (28). The human cathelicidin 
LL-37 may induce signaling pathways involved in wound closure, activating airway 
epithelial cells via EGFR, as well as neovascularization of wounds (29, 30). The late 
induction of the cathelicidins MAP29 and Dodecapeptide observed in our study could be 
involved in the process of tissue healing following inflammation. The in situ hybridization 
showed that the late upregulation of cathelicidins originated both in epithelial as well as in 
inflammatory cells, demonstrating the potential role of both these cell types in lung repair. 
Consistent with our results, the fetal lung exposed to intraamniotic LPS initially 
demonstrates injury – increased apoptosis with decreased septation and microvascular injury 
that recover despite continuous or repeated exposure to LPS (6, 17, 31).
Regarding the DAMPs, we found that expression of IL-1α was increased 12 hours after LPS 
exposure, while IL-1β expression peaked later at 2 days. IL-1α is expressed constitutively in 
epithelial and mesenchymal cells and both its precursor and mature forms are active 
transcription regulators (32). In cell injury induced by hypoxia, IL-1α is responsible for 
early recruitment of neutrophils in response to inflammation with little effect on recruitment 
of macrophages or monocytes, while IL-1β seems to be more important for maintenance of 
the inflammatory response and recruitment of macrophages (33). Our findings are consistent 
with the role described for early recruitment of inflammatory cells. Potentially, IL-1α has a 
similar role in the fetal inflammatory response being an early mediator of chemotaxis 
followed by later expression of IL-1β.
The expression of another DAMP, lactoferrin was increased at 24 hours. Epithelial cells and 
neutrophils can produce lactoferrin, and we observed it localized to the bronchial glands. 
Lactoferrin has antimicrobial properties by both chelating iron and disrupting bacterial cell 
membrane (34). Lactoferrin has the ability to bind LPS preventing further activation of the 
inflammatory response and production of pro-inflammatory cytokines (35). The increased 
expression of lactoferrin in response to chorioamnionitis has the potential to increase the 
innate ability to kill invading microorganisms while limiting local inflammatory response 
and damage. The staining pattern observed was consistent with what has been reported in 
the literature, however, no difference was observed in the immunostaining, which could be 
due to the rapid secretion of the peptide from the bronchial glands.
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Even though there was no difference in the mRNA level for HSP70, we observed increased 
immunostaining at 12 and 24 hours after LPS exposure. This difference was seen only in the 
airway epithelium and the conflicting results might be related to the localization of HSP70 
as we observed previously with a volutrauma injury (36). Besides, the discrepancy between 
immunostaining and the mRNA quantitation could be due to post-transcriptiona regulations, 
since the mRNA for HSP70 has been shown to be subject to microRNA regulation leading 
to supression of translation and polyadenylation leading the increased translation. HSP70 
appears to have cytoprotective role in the lung epithelium against LPS and hypoxia-
mediated injury (37). Expression of HMGB1 and its receptor RAGE in the lung were not 
affected by LPS exposure.
Among the pro-inflammatory cytokines IL-6 and MCP-1 had the earliest increase in 
expression at 5 hours after LPS exposure, while the remainder cytokines peaked at 2 days. 
This response pattern suggests a role of IL-6 and MCP-1 in the initiation of pulmonary 
inflammation in chorioamnionitis. We previously reported that MCP-1 is expressed in the 
lung mesenchymal cells potentially suggesting a role for these lung cells in the initiation of 
lung inflammation (38). In contrast to the early induction of IL-6 and MCP-1, TNF-α and 
IL-10 mRNAs were only increased at 2 days, suggesting that these cytokines play a 
secondary role in modulating the lung inflammation after LPS induced chorioamnionitis.
We present a novel report of the time course expression of pro- and anti-inflammatory 
cytokines in a model of chorioamnionitis. Our study provides insight on the expression of 
AMPs and DAMPs in the early and late pulmonary responses to intra-uterine inflammation. 
The early suppression of both cathelicidins and defensins could potentially increase fetal 
susceptibility to further infection. The late induction of cathelicidins MAP29 and 
dodecapeptide could be related to their role in tissue repair following inflammatory injury.
Methods
Animals
The Animal Care and Use Committees of the Cincinnati Children's Hospital Medical Center 
and University of Western Australia approved the study protocol. All procedures involving 
animals were performed at The University of Western Australia (Perth, Australia). Time-
mated Merino ewes with singleton fetuses were randomly assigned to groups for exposure to 
either 10mg of intra-amniotic LPS from Escherichia coli (Sigma Aldrich, St Louis, MO) 
diluted in 2 mL of sterile saline or 2 mL of sterile saline as control. This dose of LPS has 
been shown to induce chorioamnionitis and fetal inflammatory response (39). The 
inflammatory response of the fetal thymus was reported previously for this series of animals 
(16).
Intraamniotic LPS or saline was dosed at one of the following time points: 5 hours, 12 
hours, 24 hours, 2 days, 4 days, 8 days or 15 days with ultrasound guidance (39) prior to 
preterm delivery at 125 ± 2 days. We used 5 to 7 animals per group. Ewes were euthanized 
with 100mg/kg of intravenous pentobarbital with rapid surgical delivery of the fetus (16). 
Fetal lungs for mRNA analysis were quickly dissected and snap frozen. For histological 
Schmidt et al. Page 6
Pediatr Res. Author manuscript; available in PMC 2015 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
analysis the right upper lobe of the lung was inflated fixed with 10% buffered formalin at a 
pressure of 30 cmH2O, and further processed to embed in paraffin (40).
Relative mRNA Quantitation
Total RNA was isolated from frozen lungs after homogenization with TRIzol (Invitrogen, 
Carlsbad, CA) as previously describe (40). Reverse transcription was performed using Verso 
cDNA kit (Thermo Scientific, Waltham, MA) to produce single-strand cDNA. The genes 
IL-1β, TNF-α, MCP-1, Il-6, IL-8, IL-10, IL-1α, SBD1, SBD2, MAP29, Dodecapeptide, 
Lactoferrin, HMGB1, RAGE, and HSP70 were amplified using the cDNA template and 
sheep-specific primers along with Taqman probes (Applied Biosystems, Foster City, CA). 
The mRNA expression for each gene was normalized to the mRNA for the ribosomal 
protein 18s as internal standard. Final data were expressed as fold increase over the control 
value.
Immunohistochemistry
Sections from formalin fixed tissues in paraffin blocks were deparaffinised and rehydrated 
before microwave-assisted antigen retrieval in citric acid buffer at pH 6.0. Endogenous 
peroxidase activity was blocked with CH3OH/H2O2 treatment and were blocked with 2% 
BSA in PBS. Sections were incubated overnight at 4°C with the primary antibody diluted in 
2% serum in PBS(7). We used the following primary antibodies: Lactoferrin (Abcam, 
Cambridge, MA, dilution 1:50), HMGB1 (R&D Systems, Minneapolis, MN, dilution 1:50), 
RAGE (AbD Serotec, Oxford, UK, dilution 1:1000), HSP70 (Biogenex, San Ramon, CA, 
dilution 1:50). Sections were then washed and incubated with the appropriate species-
specific secondary antibody diluted 1:200 in 2% serum for 2 hours at room temperature. 
After further washing, antigen:antibody complexes were visualized using a Vectastain ABC 
peroxidase kit (Vector Laboratories Inc., Burlingame, CA). Antigen detection was enhanced 
with nickel-diaminobenzidine, followed by incubation with TRIS-cobalt. Slides were 
counterstained with Nuclear Fast Red for photomicroscopy.
In situ hybridization
In situ localization of mRNA was performed with digoxigenin-labeled anti-sense sheep 
riboprobes for cathelin-related peptide that cross-reacts with all sheep cathelicidins 
(Forward: TGT GGC TCC TGC TGC TGG GAT TA; Reverse: TAT GAT GCG ACA TAT 
TCG GGC TGC). Digoxigenin-labeled riboprobes (sense and anti-sense) were synthesized 
from cDNA templates using DIG RNA labeling kits (Roche Diagnostics, Germany) and 
diluted in hybridization buffer to a final concentration of 1 μg/ml. The sections were 
pretreated with 4% paraformaldehyde, treated with proteinase K, and hybridized with the 
probe overnight at 61°C, based on GC content. Sections were washed with formamide, 
treated with RNase A (100 μg/ml), and then blocked with 10% horse serum. Following 
incubation overnight at 4°C with anti-digoxigenin antibody (Roche Diagnostics), the slides 
were developed with nitro blue tetrazolium- 5-bromo-4-chloro-3-indolyl phosphate (Roche 
Diagnostics) in the absence of ambient light using dark boxes. The slides were monitored for 
color development, and then stopped with Tris-EDTA buffer. Controls for specificity of 
ribo-probe binding were done with the use of the homologous (sense) probe.
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Statistical analysis
Values are expressed and depicted in graphs as means ± standard deviation. All analysis 
were performed using the software GraphPad Prism version 5.00 for Windows (GraphPad 
Software, San Diego, CA). mRNA expression levels were compared using one-way 
ANOVA and each group was individually compare to the control group using t test. Values 
of p<0.05 were considered significant.
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Figure 1. Time-dependent changes in the expression of antimicrobial peptides (AMPs) in 
preterm fetal sheep lung after IA LPS
mRNA expression of the antimicrobial peptides A: MAP29, B: Dodecapeptide, C: SBD1, 
D: SBD2 by RT-qPCR using Taqman probes was analyzed. The AMP expression decreased 
at 24h after LPS. The expression of MAP29 and Dodecapetide increased at 4-8d while 
SBD1 and SBD2 returned to levels similar to controls. *p<0.05 compared to saline.
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Figure 2. Cellular localization of AMPs in preterm fetal sheep lung after IA LPS
Representative photomicrographs of in situ hybridization for cathelin-related peptide. 
mRNA signal localized to alveolar cells with increased staining at 8 days after LPS 
exposure. A: Control B: 8 days after intraamniotic LPS (magnification 100x for main frame 
and 400X for insert).
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Figure 3. Expression of DAMP mRNAs in preterm fetal sheep lung after IA LPS
Expression of the antimicrobial DAMP mRNAs by RT-qPCR using Taqman probes was 
performed. A: IL-α expression peaked at 12 hours, B: lactoferrin peaked 24 hours, C: 
HMGB1, D: RAGE, E: HSP70. (*p<0.05 compared to saline).
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Figure 4. Cellular localization of DAMPs in preterm fetal sheep lung after IA LPS
Representative photomicrographs showing immunostaining for the following: Lactoferrin 
depicting staining of bronchial glands and bronchial epithelial cells in control (A) and 24 
hours after LPS exposure (B) HMGB1 with diffuse and strong nuclear staining of alveolar 
cells in control (C) and 24 hours after LPS exposure (D) RAGE showed weaker staining of 
alveolar cells in control (E) and strong staining of inflammatory cells 24 hours after LPS 
exposure (F); HSP70 showing immunostaining in the epithelial airway cells in the control 
group (G), with increased staining at 24h after LPS exposure (H).
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Figure 5. Different temporal patterns of expression of pro-inflammatory cytokines/chemokines 
in preterm fetal sheep lung after IA LPS
mRNA expression of the cytokines/chemokines by RT-qPCR using Taqman probes was 
analyzed. A: IL-1β, B: TNF〈, C: MCP-1, D: IL-6, E: IL-8, F: IL-10. Different temporal 
patterns of expression were noted with early expression for IL-6 and MCP-1 and later 
expression for TNF〈 and IL-10. The expression for IL-1β, IL-8 and MCP-1 started 5-12h 
after IA LPS with a peak at 2d. (*p<0.05 compared to saline).
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Table 1
Physiological variable of preterm lambs at birth.
Group n Birth weight Sex (M/F) Cord blood pH
Saline 6 3.0 ± 0.3 3/3 7.1 ± 0.1
5h 6 3.1 ± 0.2 2/4 7.1 ± 0.1
12h 7 2.8 ± 0.2 5/2 7.0 ± 0.1
24h 7 2.8 ± 0.6 4/3 7.1 ± 0.1
2d 6 2.9 ± 0.3 3/3 7.1 ± 0.2
4d 5 3.0 ± 0.1 2/3 7.1 ± 0.2
8d 7 3.0 ± 0.4 2/5 7.2 ± 0.1
15d 7 2.9 ± 0.2 3/4 7.2 ± 0.1
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